SCHEMBL12798968

SCHEMBL12798968

Cc1ccc(-c2csc(NC(=O)c3sc4ccccc4[n+]3[O-])c2C(=O)O)c(F)c1F

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 14/20 0.43
▸ KMT2A Q03164 14/20 0.43
▸ NPC1 O15118 4/20 0.43
▸ RAB9A P51151 3/20 0.41
▸ NLRP3 Q96P20 1/20 0.41
▸ GRIN2C Q14957 1/20 0.38
▸ PKM P14618 2/20 0.38
▸ TP53 P04637 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ USP2 O75604 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ ANO1 Q5XXA6 2/20 0.37
▸ LMNA P02545 1/20 0.36
▸ MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12830730 0.85 MEN1 (0.33) MEN1KMT2ANPC1HTT
SCHEMBL1954046 0.78 LMNA (0.49) MEN1KMT2ANPC1RAB9ANLRP3
SCHEMBL14803202 0.78 MEN1 (0.58) MEN1KMT2ANPC1RAB9ANLRP3
SCHEMBL14803081 0.77 MEN1 (0.44) MEN1KMT2ANPC1RAB9ANLRP3
SCHEMBL1952279 0.77 MEN1 (0.48) MEN1KMT2ANPC1RAB9ANLRP3
SCHEMBL14803153 0.76 MEN1 (0.56) MEN1KMT2ANPC1RAB9ANLRP3
SCHEMBL14803179 0.76 MEN1 (0.47) MEN1KMT2ANPC1RAB9ANLRP3
SCHEMBL14803178 0.75 MEN1 (0.49) MEN1KMT2ANPC1RAB9ANLRP3
SCHEMBL14803251 0.75 MEN1 (0.55) MEN1KMT2ANPC1RAB9ANLRP3
SCHEMBL14803163 0.75 MEN1 (0.54) MEN1KMT2ANPC1RAB9ANLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130079348-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2013-03-28 — — US disclosed
US-7906553-B2 Substituted thiophene modulators of intracellular calcium CALCIMEDICA, INC. (US) 2011-03-15 — — US disclosed
US-20100261725-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2010-10-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100261725-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 MEN1 2958/4885KMT2A 4706/4885NPC1 262/4885
US-20130079348-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 MEN1 2958/4885KMT2A 4706/4885NPC1 262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback